Barclays Downgrades Xylem to Equal-Weight, Lowers Price Target to $104
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsDowngradesPrice Target
Barclays analyst William Grippin downgrades Xylem (NYSE:XYL) from Overweight to Equal-Weight and lowers the price target from $139 to $104.
Barclays analyst William Grippin downgrades Xylem (NYSE:XYL) from Overweight to Equal-Weight and lowers the price target from $139 to $104.